13.02

0.31% -0.04

After Hours: 13.02

Simulations Plus Inc (SLP)

Overview News Price History Option Chain Financials Why SLP Down? Discussions Forecast Stock Split Dividend History

Simulations Plus Inc stock is traded at $13.02, with a volume of 630.71K. It is down -0.31% in the last 24 hours and down -25.39% over the past month. Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Previous Close:

$13.06

Open:

$12.98

24h Volume:

630.71K

Relative Volume:

1.05

Market Cap:

$262.05M

Revenue:

$66.98M

Net Income/Loss:

$9.65M

P/E Ratio:

27.12

EPS:

0.48

Net Cash Flow:

$10.19M

1W Performance:

-0.76%

1M Performance:

-25.39%

6M Performance:

-62.06%

1Y Performance:

-68.12%

1-Day Range:

$12.83

$13.21

1-Week Range:

$12.83

$13.84

52-Week Range:

$12.39

$40.63

Simulations Plus Inc Stock (SLP) Company Profile

Name

Simulations Plus Inc

Sector

Healthcare (1161)

Industry

Health Information Services (54)

Phone

661-723-7723

Address

800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA

Employee

247

Twitter

@SimulationsPlus

Next Earnings Date

2025-04-03

Latest SEC Filings

SLP's Discussions on Twitter

Compare SLP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLP Simulations Plus Inc	13.02	262.86M	66.98M	9.65M	10.19M	0.48
VEEV Veeva Systems Inc	284.20	46.88B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	56.59	10.01B	803.32M	-709.10M	-212.68M	-7.8003
HQY Healthequity Inc	97.00	8.54B	1.15B	96.70M	-161.99M	1.09
DOCS Doximity Inc	58.75	11.03B	550.17M	201.35M	232.07M	1.00
WAY Waystar Holding Corp	36.98	6.17B	906.14M	-52.62M	89.62M	-0.3621

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-15-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Nov-15-24	Initiated	Stephens	Overweight
Jul-29-24	Initiated	KeyBanc Capital Markets	Overweight
Jul-16-24	Initiated	JMP Securities	Mkt Perform
Jun-28-24	Initiated	William Blair	Outperform
May-09-23	Initiated	BTIG Research	Buy
Oct-26-21	Upgrade	Craig Hallum	Hold → Buy
Jan-12-21	Downgrade	Craig Hallum	Buy → Hold
Oct-16-20	Initiated	Raymond James	Outperform
Sep-08-20	Initiated	Oppenheimer	Outperform
Jan-06-20	Initiated	Craig Hallum	Buy

View All

Simulations Plus Inc Stock (SLP) Latest News

Jul 31, 2025

Lost Money on Simulations Plus, Inc. (SLP)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Jul 31, 2025

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail

Jul 31, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc.SLP - PR Newswire

Jul 31, 2025

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman - PR Newswire

Jul 31, 2025

How Simulations Plus Inc. stock performs during market volatilityMulti-Year Investment Performance Summary Report - Newser

Jul 31, 2025

Fiera Capital Corp Invests $576,000 in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World

Jul 31, 2025

Jul 30, 2025

Does Simulations Plus Inc. show high probability of reboundFree Breakout Entry Signal Confirmation Tool - Newser

Jul 30, 2025

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Simulations Plus, Inc. (NASDAQ: SLP) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Morningstar

Jul 30, 2025

Did Simulations Plus, Inc. (SLP) Mislead Investors? Levi & Korsinsky Investigates - TradingView

Jul 30, 2025

Simulations Plus (SLP) Faces Investor Scrutiny After Asset - GlobeNewswire

Jul 30, 2025

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman - GlobeNewswire Inc.

Jul 30, 2025

Using Python tools to backtest Simulations Plus Inc. strategiesFree Intraday Trend Analysis for Fast Gains - Newser

Jul 30, 2025

Is a relief rally coming for Simulations Plus Inc. holdersTechnical Trade Plan with Entry Checklist - Newser

Jul 30, 2025

Using RSI to spot recovery in Simulations Plus Inc.Asset Allocation Summary With Future Outlook - Newser

Jul 30, 2025

Jul 29, 2025

Simulations Plus Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Capital Protection Trading Strategies - Newser

Jul 29, 2025

Multi asset correlation models including Simulations Plus Inc.AI-Based Stock Behavior Forecast Engine - Newser

Jul 29, 2025

Simulations Plus reports 70% success rate in AI-driven drug design - Investing.com Australia

Jul 29, 2025

Simulations Plus Announces Publication Of Experimental Results Of AIDD Collaboration With IMB PAS In ACS Medical Chemistry Letters - 富途牛牛

Jul 29, 2025

Simulations Plus: Pioneering AI-Driven Drug Design with Validated Success in RORγ/RORγT Ligand Discovery - AInvest

Jul 29, 2025

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design - Yahoo Finance

Jul 29, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jul 29, 2025